Aspirin and Dipyridamole (Teva Pharmaceuticals USA, Inc.)
Welcome to the PulseAid listing for the Aspirin and Dipyridamole drug offered from Teva Pharmaceuticals USA, Inc.. This Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE],Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Teva Pharmaceuticals USA, Inc. |
NON-PROPRIETARY NAME: | Aspirin and Dipyridamole |
SUBSTANCE NAME: | ASPIRIN; DIPYRIDAMOLE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE],Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE, EXTENDED RELEASE |
MARKETING CATEGORY NAME: | NDA AUTHORIZED GENERIC |
START MARKETING DATE: | 2015-07-01 |
END MARKETING DATE: | 0000-00-00 |
Aspirin and Dipyridamole HUMAN PRESCRIPTION DRUG Details:
Item Description | Aspirin and Dipyridamole from Teva Pharmaceuticals USA, Inc. |
LABELER NAME: | Teva Pharmaceuticals USA, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 25; 200(mg/1; mg/1) |
START MARKETING DATE: | 2015-07-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0093-3040_a82a35f5-2a9e-42c6-8598-06278e8ff939 |
PRODUCT NDC: | 0093-3040 |
APPLICATION NUMBER: | NDA020884 |
Other ASPIRIN; DIPYRIDAMOLE Pharmaceutical Manufacturers / Labelers: